Molecular Cancer Biology
A section of Cancers (ISSN 2072-6694).
Section Information
Dysregulation of the complex biological processes that control cell and tissue homeostasis, growth and development under physiological conditions is the key driver of oncogenesis, tumor progression and therapy resistance of cancer. A better understanding of the pivotal molecular events underlying these three aspects of cancer biology will aid the identification of novel targets and the development of new therapeutic approaches for the treatment of this devastating disease. This section covers all aspects of molecular and cellular biology related to the development, progression and therapy of cancer. Topics of interest include:
- oncogenesis and cancer progression;
- cancer immunology;
- drug discovery and targeted therapy;
- tumor invasion and metastasis;
- cancer stem cell biology;
- genomic instability;
- DNA damage and repair;
- cell cycle regulation;
- hypoxia;
- cancer cell metabolism;
- mechanisms of therapy resistance;
- autophagy;
- apoptosis;
- necrosis;
- senescence;
- angiogenesis;
- inflammation and cancer
Editorial Board
Topic Board
Special Issues
Following special issues within this section are currently open for submissions:
- Small Molecule Regulators of Cancer-Related Proteins: Where Are We in Precision Medicine? (Deadline: 31 May 2021)
- Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer (Deadline: 31 May 2021)
- Targeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles (Deadline: 31 May 2021)
- Genomics- and Proteomics-Driven Discoveries on Cancer Metastasis: Impacts on Therapeutics and Diagnostics (Deadline: 31 May 2021)
- Targeting Blood Vessel Components to Treat Cancer (Deadline: 31 May 2021)
- Connexins and Pannexins in Cancer Diseases and Therapy (Deadline: 31 May 2021)
- Hodgkin Lymphoma (Deadline: 31 May 2021)
- Targeting Tumor Cell-Intrinsic Checkpoint Molecules: Beyond the Control of Anti-tumor Immunity (Deadline: 1 June 2021)
- Crosstalk Between Extracellular Matrix (ECM) and Intracellular Metabolism in Cancer (Deadline: 1 June 2021)
- Blood Stem Cells in Pre-leukaemia (Deadline: 1 June 2021)
- The Isoforms of the p53 Gene Family and Their Role in Cancer and Aging：Selection Papers from International p53/p63/p73 Isoforms Workshop (Deadline: 15 June 2021)
- Epigenomic Regulation in Normal Hematopoiesis and Hematological Oncogenesis (Deadline: 30 June 2021)
- Cancer Epigenomics: New Clinical Opportunities and Challenges (Deadline: 30 June 2021)
- Multi-Omics Approaches in Oncology (Deadline: 30 June 2021)
- New Molecular Insights for GC Characterization and Treatment (Deadline: 30 June 2021)
- Tumor-Suppressor Genes in Renal Cell Carcinoma (Deadline: 30 June 2021)
- Molecular Alterations in Thyroid Cancer – with Special Focus on Diagnosis, Prognosis and Treatment (Deadline: 30 June 2021)
- Proteomics in Cancer (Deadline: 30 June 2021)
- Molecular Pathways in Cancers (Deadline: 30 June 2021)
- Genomic Alterations of Leukemia (Deadline: 30 June 2021)
- Tumor Infiltrating Lymphocytes (TIL) in Solid Tumors: Emerging Insights (Deadline: 30 June 2021)
- Novel Biomarkers and Molecular Targets in Cancer (Deadline: 30 June 2021)
- Strategies for Isolation and Phenotypic, Genetic, and Functional Characterization of Circulating Tumor Cells (Deadline: 30 June 2021)
- Uncovering the Diversity of Form and Function for Long Non-coding RNAs in Lung Cancer (Deadline: 30 June 2021)
- Phenotypic Plasticity and the Oncogenic Epithelial-Mesenchymal Transition (Deadline: 30 June 2021)
- Omics in Ovarian Cancer (Deadline: 30 June 2021)
- Molecular Advances in Diffuse Large B-Cell Lymphoma (Deadline: 1 July 2021)
- Mechanisms of Resistance in EGFR-Mutated Non-Small Cell Lung Cancer (Deadline: 15 July 2021)
- The Role of Vasohibin-1 and Vasohibin-2 in Cancer (Deadline: 15 July 2021)
- Understanding and Modelling Metabolic Reprogramming in Breast Cancer (Deadline: 20 July 2021)
- Exosome Biology for Nucleic Acid Medicine—From Bench to Bed (Deadline: 31 July 2021)
- The Migration and Invasion of Oral Squamous Carcinoma Cells: Matrix, Growth Factor and Signaling Involvement (Deadline: 31 July 2021)
- Large Granular Lymphocytic Leukemia: Genomics and Immunome (Deadline: 31 July 2021)
- Hereditary Gastric Cancer—Molecular Basis and Diagnosis (Deadline: 31 July 2021)
- Circular RNAs: New Insights into the Molecular Biology of Cancer (Deadline: 31 July 2021)
- Cancer, Immune-Control and Immunometabolism (Deadline: 31 July 2021)
- PARPs in Cancer (Deadline: 1 August 2021)
- Chronic Lymphocytic Leukaemia (CLL) (Deadline: 1 August 2021)
- Molecular Pathogenesis and Management of Anaplastic Large Cell Lymphoma (Deadline: 1 August 2021)
- Metastatic Pancreatic Ductal Adenocarcinoma (Deadline: 13 August 2021)
- The Role of p53 Family in Cancer (Deadline: 30 August 2021)
- Adult T-cell Leukemia/Lymphoma (Deadline: 30 August 2021)
- CD4 T Cells and Cancer Immune Response (Deadline: 31 August 2021)
- Insight into Fatty Acid Metabolism in Colorectal Cancer (Deadline: 31 August 2021)
- Systems Biology and Intra-tumor Heterogeneity (Deadline: 31 August 2021)
- Cell Adhesion Molecules in Metastasis (Deadline: 31 August 2021)
- Genome/DNA/RNA Mutations and Cancer (Deadline: 31 August 2021)
- Role of Small GTPase Signaling in Tumorigenesis (Deadline: 31 August 2021)
- The Role of PGRMC1 and PGRMC2 in Metabolism and Cancer Biology (Deadline: 31 August 2021)
- The Role of the Ubiquitin-Proteasome-System in Human Cancer (Deadline: 31 August 2021)
- Updates on Molecular Targeted Therapies for CNS Tumors (Deadline: 1 September 2021)
- Models, Mechanisms, and Biomarkers of Prostate Cancer Progression (Deadline: 15 September 2021)
- miRNAs: New Insights in Tumor Biology (Deadline: 15 September 2021)
- WNT Signaling Pathways in Cancer (Deadline: 15 September 2021)
- p53 and Ralbp1 in Carcinogenesis (Deadline: 15 September 2021)
- Targeting KRAS: Elucidating Mechanisms of Sensitivity and Resistance (Deadline: 30 September 2021)
- Metastatic Brain Tumors Research (Deadline: 30 September 2021)
- Functional Genomics of Cancer (Deadline: 30 September 2021)
- Calcium Signaling Remodeling and Functional Role in Cancer Cells (Deadline: 30 September 2021)
- Research in MicroRNA Profiling of Prostate Cancer (Deadline: 30 September 2021)
- Role of Stromal Cells in Determining Tumor and Cancer Stem Cell Behaviors and Therapeutic Response (Deadline: 30 September 2021)
- Molecular Genetics and Treatment of Chronic Myeloid Leukemia (Deadline: 30 September 2021)
- Advances in Aggressive Subtypes of Cancers Caused by Inherited Mutations in DNA Damage Repair Genes (Deadline: 30 September 2021)
- Experimental and Clinical Advances in Counteracting Progression of Solid Cancers (Deadline: 30 September 2021)
- The Roles of microRNAs in Cancer Aggressiveness and Drug Resistance (Deadline: 30 September 2021)
- New Insights into Hereditary Cancer Syndromes (Deadline: 30 September 2021)
- The Emerging Hallmarks of Cancer Metabolism for Precision Oncology Applications (Deadline: 1 October 2021)
- Molecular Mechanisms Underlying Resistance and New Therapeutic Approaches in Pancreatic Cancer (Deadline: 1 October 2021)
- CAR T Cells in Solid Tumors: Current State and Future Direction (Deadline: 1 October 2021)
- Genomic Instability and the DNA Damage Repair Response in Malignant Brain Tumors: Factors Underpinning Cancer Progression, Treatment Resistance, and Inter/Intra-Tumoral Heterogeneity (Deadline: 30 October 2021)
- Mesenchymal-Epithelial Transition in Cellular Reprogramming and Cancer (Deadline: 30 October 2021)
- The Role of Mitochondrial Ion Channels and Transporters in Cancer Development and Progression (Deadline: 30 October 2021)
- Tumor-Promoting Functions of DNA Damage and Stress Response Signaling (Deadline: 30 October 2021)
- Cell Cycle Proteins as Promising Targets in Cancer Therapy (Deadline: 30 October 2021)
- Resistance Mechanisms in Malignant Brain Tumors (Deadline: 31 October 2021)
- Intra-tumoral Heterogeneity—Experimental Models, Molecular Mechanisms and Clinical Relevance (Deadline: 31 October 2021)
- Cytokine and Steroid Hormone Signaling in Prostate Cancer (Deadline: 31 October 2021)
- Hormone-Associated Cancers (Deadline: 31 October 2021)
- Lung Adenocarcinoma: Issues and Challenges (Deadline: 31 October 2021)
- Advances in Tumor Glycans (Deadline: 31 October 2021)
- Hippo Signaling Pathway in Cancers (Deadline: 31 October 2021)
- Protein Synthesis in Cancer Cells: Mechanisms and Novel Targeted Therapies (Deadline: 31 October 2021)
- Cytokines in Cancer Immunotherapy (Deadline: 31 October 2021)
- Chemerin Signaling in Cancer (Deadline: 31 October 2021)
- Molecular Targets for Head and Neck Cancer (Deadline: 31 October 2021)
- CRISPR/Cas9 in Cancer Research (Deadline: 31 October 2021)
- Molecular Mechanisms Underlying Tumor Onset and Progression in Liver Cancers (Deadline: 15 November 2021)
- Metabolic Reprogramming as an Exploitable Vulnerability in NSCLC (Deadline: 15 November 2021)
- MAPK in Cancers: from Signalling Pathways to Therapeutic Targets (Deadline: 30 November 2021)
- Unraveling the Etiology, Therapeutics, and Molecular Signatures of Triple-Negative Breast Cancer (Deadline: 30 November 2021)
- The Endocrine Basis of Breast Cancer (Deadline: 30 November 2021)
- Signalling pathways in metabolic disease and cancer (Deadline: 30 November 2021)
- O-GlcNAcylation and Cancer (Deadline: 30 November 2021)
- Molecular Pharmacology of Anti-Cancer Drugs (Deadline: 30 November 2021)
- Rare Skin Cancers: Recent Advances in Classification and Management (Deadline: 10 December 2021)
- Metabolism in Ovarian Cancer (Deadline: 15 December 2021)
- Autologous Stem Cell Transplantation for Neoplasias (Deadline: 30 December 2021)
- Alternative and Aberrant Splicing in Cancer: How Can We Fix It? (Deadline: 31 December 2021)
- Cancer Drug Resistance: An Epigenetic Approach (Deadline: 31 December 2021)
- The Role and Therapeutic Target Potential of RBPs in Cancer (Deadline: 31 December 2021)
- Analyze Cancer Screening and Make Predictions and Prognoses Using Biomarkers (Deadline: 31 December 2021)
- New Insights into the Molecular Mechanism of Epithelial Plasticity in Cancer (Deadline: 31 December 2021)
- Cancer Therapy and the p53-MDM2 Autoregulatory Feedback Loop (Deadline: 31 December 2021)
- The Bright and Dark Sides of Apoptosis and Other Modes of Cell “Death” in Cancer Therapy (Deadline: 31 December 2021)
- Mechanism Underlying Tumor Relapse and Targeted Treatment Strategies (Deadline: 31 December 2021)
- Mitochondria and Metabolism of Pancreatic Adenocarcinoma Cells (Deadline: 31 December 2021)
- Non-Hodgkin Lymphoma in Children (Deadline: 31 December 2021)
- Targeted Therapies for the Treatment of Glioblastoma (Deadline: 31 December 2021)
- Aberrant Signaling Pathways in Pancreatic Cancer (Deadline: 10 January 2022)
- Molecular Mechanism of the Interaction Between Cells and Extracellular Matrix in Cancer Progression (Deadline: 20 January 2022)
- Role of Oxidative Stress in Cancer (Deadline: 30 January 2022)
- Inside Cancer Genomics: From Structure to Therapy (Deadline: 31 January 2022)
- Stromal-Epithelial Interactions in Cancer Progression and Therapy Response (Deadline: 15 February 2022)
- Alterations in Cis-Regulatory Elements in Human Cancer (Deadline: 28 February 2022)
- Causes and Consequences of Chromosomal Instability in Cancer (Deadline: 31 March 2022)
- Homeobox Only Protein Homeobox (HOPX) in Cancer Research (Deadline: 31 March 2022)
- Adhesive Networks in Cancer (Deadline: 30 April 2022)
Topical Collections
Following topical collections within this section are currently open for submissions:
